Patents by Inventor Jacques Grange

Jacques Grange has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
    Patent number: 5705522
    Abstract: A new family of compounds having anti-inflammatory, anti-viral, and brocho-dilating activity having the following linear and cyclic formulas: ##STR1## and compositions of these, which alone, and in combination with reverse transcriptase inhibitors thereby resulting in an additive or synergistic effect, are useful in inhibiting or suppressing viruses including those exhibiting retroviral replication, or in treating viruses including a retrovirus such as HIV in a human cell population and methods of using these compositions, compounds, and salts thereof.
    Type: Grant
    Filed: February 13, 1996
    Date of Patent: January 6, 1998
    Assignee: Compagnie de Developpement Aguettant S.A.
    Inventors: Farid Hamedi-Sangsari, Fabienne Nugier, Thierry Vallet, Jacques Grange, Jorge Vila
  • D-aspartic acid .beta.-hydroxamate for the treatment of viral infections and tumors
    Patent number: 5571839
    Abstract: Beta-hydroxamate D-aspartic acid as a medicine, in particular for treating infectious diseases caused by retroviruses, especially those that cause AIDS, as well as for treating tumors.
    Type: Grant
    Filed: March 19, 1993
    Date of Patent: November 5, 1996
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Jorge Vila, Nicole Thomasset, Farid Hamedi Sangsari, Jacques Grange